Sign in
CompletedNo phase

Amplify Gait to Improve Locomotor Engagement in Spinal Cord Injury

Key facts

Who runs it
VA Office of Research and Development
Where
Hines, United StatesSee the site
Trial code
Status
Completed
People taking part
38 people enrolled
Started
15 Oct 2020
Ended
31 Mar 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Gait training performed on a treadmill
  • Gait training performed in a Movement Amplification Environment
Record updated
29 May 2025

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Medically stable with medical clearance from a physician to participate
  • Neurologic level of the SCI between C1-T10 with American Spinal Injury Association (ASIA) Impairment Scale (AIS) C or D
  • > 6 months since initial injury
  • Passive range of motion of the legs within functional limits and not restricting the ability to engage in locomotor training
  • Able to ambulatory 10m with no physical assistance, use of assistive devices (e.g. single cane, rolling walker), and/or braces that do not cross the knee joint (e.g. ankle foot orthosis) are permitted
  • Able to provide transportation to and from the testing location

Who cannot take part

  • Concomitant central or peripheral neurological injury (i.e. traumatic head injury or peripheral nerve damage in lower limbs)
  • Enrollment in concurrent physical therapy or research involving locomotor training
  • Severe cardiovascular and pulmonary disease
  • History of recurrent fractures or known orthopedic problems in the lower extremities (i.e. heterotopic ossification)
  • Excessive spasticity in the lower limbs as measured by a score of > 3 on the Modified Ashworth Scale
  • Inability to tolerate 30 minutes of standing
  • Inability to provide informed consent due to cognitive impairments
  • Presence of unhealed decubiti or other skin compromise
  • Use of braces/orthotics crossing the knee joint
  • Known pregnancy

Where in United States

  • Edward Hines Jr. VA Hospital, Hines, ILHines, United States

About the trial

What the trial wants to find out

Spinal cord injury (SCI) affects ~42,000 Veterans. The VA provides the single largest network of SCI care in the nation. The lifetime financial burden of SCI can exceed $3 million. A major cost of SCI is impaired mobility. Limited mobility contributes to decreased ability to work, increased care requirements, secondary injury, depression, bone mineral density loss, diabetes, and decreased cardiovascular health. Among ambulatory individuals with iSCI, residual balance deficits are common and are strongly correlated with both functional walking ability and participation in walking activities. The development of effective rehabilitation tools to improve dynamic balance would substantially improve quality of life for Veterans living with iSCI. Improving mobility through interventions that enhance dynamic balance would positively impact health, independence, and the ability to integrate into social, intellectual, and occupational environments.

The 2 groups in the trial

  • Treadmill groupExisting treatment, for comparison

    Participants randomized to the Treadmill group will complete high intensity gait training on a treadmill.

    Treatment: Gait training performed on a treadmill

  • Movement Amplification groupTreatment being tested

    The locomotor training protocol described for the Treadmill group will be used for the Movement Amplification group with one exception. The Movement Amplification group will perform all gait training within the movement amplification environment.

    Treatment: Gait training performed in a Movement Amplification Environment

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Amplify Gait to Improve Locomotor Engagement in Spinal Cord Injury (AGILE SCI) Trial
Publications
Record updated
29 May 2025